 
        Collagenase injections: A non-surgical modality in treating Dupuytren's Disease
 
                                                    Collagenase injections: A non-surgical modality in treating Dupuytren's Disease
Injectable collagenase Clostridium histolyticum: A new nonsurgical treatment for Dupuytren's disease
Journal of Hand Surgery American; 2010; 35(A); 2027-2038Synopsis
66 patients with contractures, affecting either the metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joints, were randomized to receive Xiaflex (collagenase clostridium histolyticum) or placebo local injection. The results of the 9-month long trial indicated that patients who received Xiaflex displayed significantly greater range of motion and a significantly decreased degree of joint c...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.